ENO2 and lung cancer: More traditional biomarkers like CEA, ProGRP, SCC, NSE, and CYFRA21-1 are commonly used for the diagnosis and management indicators of lung cancer (Mishra and Verma 2010; NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).